MedTrace Logo

PCR Based CEUS in BI RADS 4A Nodules

NCT04929054 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2021-07-15

No results posted yet for this study

Summary

The aim of this study was to investigate the added value of Principal Component Regression (PCR) based contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS).

Conditions

Interventions

DIAGNOSTIC_TEST

imaging

ultrasound and contrast enhanced ultrasound for BI RADS4A breast modules

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • pintong Huang · SAHZJU

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-05-30
Completion
2021-12-30

Countries

  • China

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929054 on ClinicalTrials.gov